Strategies for Discontinuing Omalizumab in Patients With Chronic Urticaria: Real-World Findings

Journal of Allergy and Clinical Immunology - United States
doi 10.1016/j.jaci.2018.12.920
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Omalizumab Treatment in Patients With Chronic Spontaneous Urticaria

Bőrgyógyászati és Venerológiai Szemle
2015English

Effectiveness of Omalizumab in Adolescent and Adult Patients With Chronic Idiopathic/Spontaneous Urticaria: A Systematic Review of “Real-World” Evidence

Expert Opinion on Biological Therapy
Drug DiscoveryClinical BiochemistryPharmacology
2018English

Transient Hair Loss in Patients With Chronic Spontaneous Urticaria Treated With Omalizumab

European Annals of Allergy and Clinical Immunology
AllergyImmunology
2017English

Omalizumab in Chronic Urticaria: A Comprehensive Review

Turkderm Deri Hastaliklari ve Frengi Arsivi
DermatologyInfectious Diseases
2018English

Omalizumab Updosing Allows Disease Activity Control in Refractory Patients With Chronic Spontaneous Urticaria

British Journal of Dermatology
DermatologyMedicine
2018English

Omalizumab Response in Patients With Chronic Idiopathic Urticaria: Insights From the XTEND-CIU Study

Journal of the American Academy of Dermatology
Dermatology
2018English

Efficacy of Omalizumab in Treatment-Resistant Chronic Spontaneous Urticaria

Asim, Allerji, Immunoloji
Respiratory MedicinePulmonaryAllergyImmunology
2018English

Omalizumab for Chronic Idiopathic Urticaria: Potential to Taper Dose and Frequency?

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Refractory Chronic Spontaneous Urticaria Treated With Omalizumab in an Adolescent With Common Variable Immunodeficiency

Frontiers in Immunology
AllergyImmunology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy